TargetMol

Desmorpholinyl Navitoclax-NH-Me

Product Code:
 
TAR-T39910
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T39910-1mg1mg£182.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39910-5mg5mg£349.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39910-10mg10mg£535.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39910-1mL1 mL * 10 mM (in DMSO)£541.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39910-25mg25mg£820.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39910-50mg50mg£1,091.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39910-100mg100mg£1,428.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Desmorpholinyl Navitoclax-NH-Me is a Bcl-xL inhibitor. Desmorpholinyl Navitoclax-NH-Me and a CRBN ligand for the E3 ubiquitin ligase can be used in the synthesis of PROTAC BCL-XL degrader XZ739 [1] [2] .
CAS:
2365172-82-1
Formula:
C44H51ClF3N5O5S3
Molecular Weight:
918.55
Pathway:
Apoptosis
Purity:
0.98
SMILES:
CC(C)(CC1)CC(CN(CC2)CCN2c(cc2)ccc2C(NS(c(cc2)cc(S(C(F)(F)F)(=O)=O)c2N[C@H](CCNC)CSc2ccccc2)(=O)=O)=O)=C1c(cc1)ccc1Cl
Target:
BCL

References

Guangrong Zheng, et al. Agents de d?gradation de prot?ines bcl-2 pour le traitement du cancer. WO2019144117A1.